GSK
GlaxoSmithKline PLC
50.50$
+0.3%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 31.8% | 37.0% | 33.3% | 34.3% | 33.2% | 35.1% | 32.6% | 33.1% | 32.6% | 28.2% | 28.8% | 27.6% | |
| 68.2% | 63.0% | 66.7% | 65.7% | 66.8% | 64.9% | 67.4% | 66.9% | 67.4% | 71.8% | 71.2% | 72.4% | |
| 15.0% | 14.9% | 13.0% | 14.8% | 12.6% | 13.5% | 19.7% | 20.3% | 18.7% | 20.5% | 20.4% | 23.0% | |
| 35.8% | 38.6% | 33.6% | 32.0% | 32.2% | 33.8% | 30.5% | 28.6% | 28.5% | 30.9% | 35.1% | 27.8% | |
| 52.5% | 19.8% | 57.4% | 52.2% | 49.0% | 44.2% | 42.9% | 49.3% | 45.5% | 49.5% | 58.3% | 46.9% | |
| 15.6% | 43.1% | 9.3% | 13.5% | 17.8% | 20.6% | 24.6% | 17.6% | 21.9% | 22.2% | 12.8% | 25.5% | |
| 3.0% | 3.2% | 2.6% | 2.4% | 2.4% | 2.7% | 3.7% | 3.2% | 2.9% | 2.6% | 2.1% | 2.1% | |
| 12.9% | 44.0% | 7.0% | 11.7% | 15.6% | 18.4% | 21.2% | 14.6% | 19.2% | 20.0% | 11.1% | 22.7% | |
| 0.6% | 9.0% | 3.1% | 4.5% | 2.4% | 2.8% | 0.3% | 0.3% | 2.4% | 2.5% | 1.7% | 3.4% | |
| 12.0% | 35.2% | 3.3% | 5.1% | 11.8% | 13.8% | 23.6% | 17.8% | 51.0% | 16.2% | 8.2% | 17.5% | |
| 22.4% | 53.9% | 15.9% | 20.5% | 23.8% | 27.3% | 33.1% | 26.3% | 29.3% | 29.9% | 21.3% | 31.8% |
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.